Stock Price
12.50
Daily Change
-0.08 -0.64%
Monthly
23.58%
Yearly
-70.41%
Q3 Forecast
12.48

Tandem Diabetes Care reported $-1851000 in EBITDA for its fiscal quarter ending in June of 2025.



Financials
Assets USD 875.74M
Cost of Sales USD 114.82M
Current Assets USD 614.82M
Debt USD 449.01M
EBIT USD -31.86M
EBITDA USD -1.85M
Employees 2.65K
Interest Income USD 4.19M
Loan Capital USD 309.15M
Net Income USD -52.4M
Operating Expenses USD 272.54M
Operating Profit USD -31.86M
Pre-Tax Profit USD -57.72M
Sales Revenues USD 240.68M
Stock USD 142.57M
Trade Creditors USD 55.84M
Trade Debtors USD 128.44M

Ebitda Change Date
Abbott USD 3.05B 870M Jun/2025
Align Technology USD 137.61M 77.61M Mar/2025
AtriCure USD 15.35M 16.22M Jun/2025
Baxter International USD 325M 251M Mar/2025
Becton, Dickinson and Co. USD 1.47B 81M Jun/2025
Boston Scientific USD 1.36B 16M Mar/2025
Cooper Companies USD 272.7M 5.8M Jul/2025
Dexcom USD 308.8M 115.1M Jun/2025
Edwards Lifesciences USD 411.3M 15.3M Mar/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Globus Medical USD 208.68M 44.48M Jun/2025
ICU Medical USD 100.31M 36.51M Jun/2025
Insulet USD 157.5M 47M Jun/2025
Integra LifeSciences USD -472218000 536.09M Jun/2025
Intuitive Surgical USD 898.7M 317.2M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Masimo USD 72M 17.3M Jun/2025
Medtronic USD 2.31B 400M Jul/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Stryker USD 1.46B 49M Jun/2025
Tandem Diabetes Care USD -1851000 28.33M Jun/2025
Teleflex USD 222.67M 27.85M Jun/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025